JP2009541332A5 - - Google Patents

Download PDF

Info

Publication number
JP2009541332A5
JP2009541332A5 JP2009516593A JP2009516593A JP2009541332A5 JP 2009541332 A5 JP2009541332 A5 JP 2009541332A5 JP 2009516593 A JP2009516593 A JP 2009516593A JP 2009516593 A JP2009516593 A JP 2009516593A JP 2009541332 A5 JP2009541332 A5 JP 2009541332A5
Authority
JP
Japan
Prior art keywords
oxime
alkyl
aryl
amino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009516593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009541332A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/014758 external-priority patent/WO2008130368A2/en
Publication of JP2009541332A publication Critical patent/JP2009541332A/ja
Publication of JP2009541332A5 publication Critical patent/JP2009541332A5/ja
Pending legal-status Critical Current

Links

JP2009516593A 2006-06-23 2007-06-25 転写因子調節化合物およびその使用法 Pending JP2009541332A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81598406P 2006-06-23 2006-06-23
PCT/US2007/014758 WO2008130368A2 (en) 2006-06-23 2007-06-25 Transcription factor modulating compounds and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2009541332A JP2009541332A (ja) 2009-11-26
JP2009541332A5 true JP2009541332A5 (https=) 2010-08-12

Family

ID=39796835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516593A Pending JP2009541332A (ja) 2006-06-23 2007-06-25 転写因子調節化合物およびその使用法

Country Status (8)

Country Link
US (1) US20090170812A1 (https=)
EP (1) EP2038274A2 (https=)
JP (1) JP2009541332A (https=)
CN (1) CN101626765B (https=)
AU (1) AU2007351886A1 (https=)
CA (1) CA2656157A1 (https=)
IL (1) IL195992A0 (https=)
WO (1) WO2008130368A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681813A1 (en) * 2007-03-27 2009-01-08 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US8647642B2 (en) 2008-09-18 2014-02-11 Aviex Technologies, Llc Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US20110177147A1 (en) * 2010-01-21 2011-07-21 General Electric Company Stable biocidal delivery systems
CN102617561B (zh) * 2012-02-21 2014-05-07 常州方圆制药有限公司 2-苄硫基苯并杂环衍生物、其制备方法及其医药用途
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN108047216B (zh) * 2017-12-06 2020-11-10 石家庄学院 一种3,4-二苯基吡唑化合物及其制备和应用
CN109265412B (zh) * 2018-11-19 2020-06-02 大连大学 一种用于检测氟离子的探针化合物及其检测方法
CN111269293B (zh) * 2018-12-04 2021-10-29 中国科学院微生物研究所 一种感应缬氨酸信号的转录因子及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300505A (en) * 1964-12-07 1967-01-24 Ciba Geigy Corp Ether-2-r-substituted benzimidazoles and derivatives and acid addition salts thereof
US3429890A (en) * 1964-12-31 1969-02-25 Merck & Co Inc Certain 2-thiazolylbenzimidazole-1-oxy derivatives
US3325356A (en) * 1965-08-20 1967-06-13 Merck & Co Inc Compositions and method for treating helminthiasis
US3449498A (en) * 1965-11-18 1969-06-10 Ciba Geigy Corp Analgesic compositions of a 4-aminoal-kylamino-quinazoline and 1-amino-alkoxybenzimidazole
GB1141936A (en) * 1966-03-26 1969-02-05 Shionogi & Co Improvements in or relating to benzimidazole derivatives
US3549754A (en) * 1969-04-21 1970-12-22 Merck & Co Inc Combination of 2-substituted benzimidazoles and substituted phenothiazines in the treatment of helminthiasis
US3686110A (en) * 1970-02-27 1972-08-22 Meuch & Co Inc 1-oxybenzimidazoles
US3873558A (en) * 1970-03-05 1975-03-25 Merck & Co Inc Process for preparing 1,5-substituted or 1,6-substituted benzimidazoles
US3646049A (en) * 1970-03-05 1972-02-29 Merck & Co Inc Acylaminobenzimidazole derivatives
US5552426A (en) * 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
JP2000516611A (ja) * 1996-08-14 2000-12-12 ワーナー―ランバート・コンパニー Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
AU6328498A (en) * 1997-02-21 1998-09-09 Hybridon, Inc. Oligonucleotides specific for the (marorab) operon
US5942532A (en) * 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
AU4196199A (en) * 1998-05-22 1999-12-13 Tufts University Mara family helix-turn-helix domains and their methods of use
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6204264B1 (en) * 1998-09-21 2001-03-20 Shiseido Co., Ltd. Benzimidazole derivative, hair growth promoter and external composition for skin using the same
SI1194425T1 (sl) * 1999-06-23 2005-12-31 Sanofi Aventis Deutschland Substituirani benzimidazoli
WO2002036580A2 (en) * 2000-10-31 2002-05-10 Lynn Bonham Benzoxazole lpaat- beta inhibitors and uses thereof
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
AU2002364611A1 (en) * 2001-12-31 2003-07-24 The Ohio State University Research Foundation Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications
EP1472245A2 (en) * 2002-02-06 2004-11-03 Vertex Pharmaceuticals Incorporated Heteroaryl compounds useful as inhibitors of gsk-3
JP4481011B2 (ja) * 2002-03-05 2010-06-16 トランス テック ファーマ，インコーポレイテッド リガンドのｒａｇｅとの相互作用を阻害する単環式および二環式アゾール誘導体
AU2002951247A0 (en) * 2002-09-06 2002-09-19 Alchemia Limited Compounds that interact with kinases
WO2004041209A2 (en) * 2002-11-01 2004-05-21 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP1742637A4 (en) * 2004-04-23 2011-06-08 Paratek Pharm Innc TRANSCRIPTION FACTOR MODULATION COMPOUNDS AND METHODS OF USE
US8334290B2 (en) * 2005-10-31 2012-12-18 Merck Sharp & Dohme Corp. CETP inhibitors
KR20090075854A (ko) * 2006-10-20 2009-07-09 엔.브이.오가논 ＰＫＣθ 억제제로서의 푸린
CA2681813A1 (en) * 2007-03-27 2009-01-08 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US20110059962A1 (en) * 2009-04-22 2011-03-10 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2009541332A5 (https=)
CA2504448A1 (en) Transcription factor modulating compounds and methods of use thereof
JP2017517567A5 (https=)
JP2016501864A5 (https=)
SI2344129T1 (en) AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS
IL165715A (en) 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
CA2433197A1 (en) Gyrase inhibitors and uses thereof
JP2005533061A5 (https=)
WO2011101710A1 (en) Efflux pump inhibitors
RU2018122505A (ru) Макроциклические антибиотики широкого спектра действия
EP2814483A2 (en) Methods of treating bacterial infections
JP2016528257A5 (https=)
CA3030532C (en) Combination comprising zidovudine and a carbapenem
HRP20250815T1 (hr) Derivati boronične kiseline i njihova terapijska upotreba
RU2016107436A (ru) Линейные пептидные антибиотики
JP2020507564A5 (https=)
JP2022137011A5 (https=)
RU2018122498A (ru) Макроциклические антибиотики широкого спектра действия
JP2019502659A5 (https=)
US20130059774A1 (en) Efflux pump inhibitors
JP2021528449A5 (https=)
JP7577376B2 (ja) ジドブジン及び抗微生物化合物を含む組み合わせ
CN120225191A (zh) 抗微生物组合
JP2011522797A5 (https=)
EP4662327A1 (en) Methods for the determination of susceptibility of siderophore beta-lactams